All transactions

Every Form 4 row this person reported, newest first

SourceSEC EDGARForm 4Reporting owner CIK 1494730 on EDGAR ↗

Quinlan Paul T Insider Trading -- Recent SEC Form 4 Transactions

Quinlan Paul T (CIK 1333277) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-21). Recent activity: Buy ORKA (10,000 shares), Sell ORKA (2,900 shares), Sell ORKA (3,832 shares), Sell ORKA (601 shares), Sell ORKA (2,667 shares). Source: SEC Form 4.

Date

Company

Role

Type

Value

2026-09-21

Date	Company	Role	Type	Shares	Value
2026-09-21	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Buy	10,000	$78,000
2026-09-21	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	2,900	$267,870
2026-09-21	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	3,832	$357,592
2026-09-21	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	601	$56,760
2026-09-21	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	2,667	$254,196
2026-09-15	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	1,039	$99,443
2026-08-14	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Buy	10,000	$78,000
2026-08-14	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Buy	42,000	$525,000
2026-08-14	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	3,630	$384,963
2026-08-14	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	10,434	$1.1M
2026-08-14	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	14,696	$1.6M
2026-08-14	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	10,200	$1.1M
2026-08-14	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	9,193	$1.0M
2026-08-14	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	3,847	$427,547
2026-06-15	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	733	$51,083
2026-03-17	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Sell	733	$30,273
2026-01-23	Oruka Therapeutics, Inc. (ORKA)	General Counsel	Buy	32,500	$0